search
Back to results

Internal Iliac Artery Ligation and Abnormally Invasive Placenta

Primary Purpose

Placenta Percreta

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
internal iliac artery ligation
Cesarean Hysterectomy
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Placenta Percreta

Eligibility Criteria

20 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • females with pre-operative diagnosis of abnormally invasive placenta

Exclusion Criteria:

  • refusal to get enrolled in the study

Sites / Locations

  • Kasr el aini hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Internal Iliac artery ligation group

Hysterectomy only

Arm Description

in this group the patients will undergo bilateral internal iliac artery ligation prior to the hysterectomy procedure

in this group patients will undergo cesarean hysterectomy only

Outcomes

Primary Outcome Measures

amount of intra-operative hemorrhage

Secondary Outcome Measures

Full Information

First Posted
March 31, 2016
Last Updated
April 14, 2017
Sponsor
Cairo University
search

1. Study Identification

Unique Protocol Identification Number
NCT02728232
Brief Title
Internal Iliac Artery Ligation and Abnormally Invasive Placenta
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
April 2016 (Actual)
Primary Completion Date
April 1, 2017 (Actual)
Study Completion Date
April 1, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This trial is set to detect the impact of bilateral internal iliac artery ligation on the amount of intra-operative blood loss during the hysterectomy procedure done for the management of abnormally invasive placenta

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Placenta Percreta

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Internal Iliac artery ligation group
Arm Type
Experimental
Arm Description
in this group the patients will undergo bilateral internal iliac artery ligation prior to the hysterectomy procedure
Arm Title
Hysterectomy only
Arm Type
Active Comparator
Arm Description
in this group patients will undergo cesarean hysterectomy only
Intervention Type
Procedure
Intervention Name(s)
internal iliac artery ligation
Intervention Type
Procedure
Intervention Name(s)
Cesarean Hysterectomy
Primary Outcome Measure Information:
Title
amount of intra-operative hemorrhage
Time Frame
2-3 hours

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: females with pre-operative diagnosis of abnormally invasive placenta Exclusion Criteria: refusal to get enrolled in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmed M Hussein, MD
Organizational Affiliation
Cairo University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kasr el aini hospital
City
Cairo
ZIP/Postal Code
12211
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Internal Iliac Artery Ligation and Abnormally Invasive Placenta

We'll reach out to this number within 24 hrs